Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | METAP1 | P53582 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25493745 | 0.87 | TP53 (0.47) | KDM4ETDP1ALOX15L3MBTL1SLC2A1 | |
| SCHEMBL20169564 | 0.80 | KDM4E (0.37) | KDM4ETDP1ALDH1A1CYP1A2RAB9A | |
| SCHEMBL22147418 | 0.78 | CNR1 (0.37) | KDM4ETDP1 | |
| SCHEMBL22650171 | 0.77 | KDM4E (0.36) | KDM4ETDP1TP53ALDH1A1RAB9A | |
| SCHEMBL19101609 | 0.76 | TSHR (0.32) | KDM4ETDP1ALOX15L3MBTL1ALDH1A1 | |
| SCHEMBL20903539 | 0.76 | KDM4E (0.42) | KDM4ETDP1L3MBTL1TP53ALDH1A1 | |
| SCHEMBL21743331 | 0.73 | HSP90AA1 (0.35) | KDM4ETDP1ALOX15L3MBTL1SLC2A1 | |
| SCHEMBL20169567 | 0.72 | KAT6A (0.35) | KDM4ETDP1ALOX15L3MBTL1TP53 | |
| SCHEMBL24728527 | 0.70 | L3MBTL1 (0.38) | KDM4EL3MBTL1TP53ALDH1A1CYP1A2 | |
| SCHEMBL20363506 | 0.70 | KDM4E (0.43) | KDM4ETDP1ALOX15L3MBTL1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024044619-A2 | METHODS OF AND DEVICES/APPARATUS FOR DETECTING, TRIGGERING, AND USING CELL-TO-CELL COMMUNICATION | IMMUNOLIGHT, LLC (US) | 2024-02-29 | — | — | WO | disclosed |
| US-11833367-B2 | Methods, devices, and compositions for measuring and inducing cell-to-cell communication, and therapeutic uses thereof | IMMUNOLIGHT, LLC. | 2023-12-05 | — | — | US | disclosed |
| US-20200114164-A1 | METHODS, DEVICES, AND COMPOSITIONS FOR MEASURING AND INDUCING CELL-TO-CELL COMMUNICATION, AND THERAPEUTIC USES THEREOF | IMMUNOLIGHT, LLC. (US) | 2020-04-16 | — | — | US | disclosed |
| US-10263194-B2 | Light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2019-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11833367-B2 | Methods, devices, and compositions for measuring and inducing cell-to-cell communication, and therapeutic uses thereof | CD47, PBK, EPCAM | KDM4E 4585/4885TDP1 1698/4885ALOX15 761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.